RCTs will guide you through conception, implementation and publication of studies performed either from alone or paired secondary data (i.e. French Claim Data base SNDS/ registry) by probabilistic or direct pairing. Those data may come from:
| The French Claim Data base (SNDS : DCIR, EGB, PMSI) | ||
| Clinical trials | ||
| Registry or observational studies databases | ||
| Connected devices | ||
| Prospective studies | ||
| Any real-world evaluation: efficiency, good use, safety, therapeutic strategy, etc. | ||
| Your Market Access Studies: Targeted or Reached Population, disease burden | ||
| Your cost studies for the development of models for the CEESP | ||
| Your post-registration studies at the request of authorities | ||
| In the dynamic analysis of healthcare pathways with data-science and AI methods | ||
| In pharmaco-economics | ||
| In epidemiology and pharmacoepidemiology (indicators for drug exposure) | ||
| Dans la lecture de l’information codée dans le SNDS et l’élaboration d’algorithmes de sélection de populations et d’identification d’évènements d’intérêt | ||
| In reading coded information in the SNDS and in developing algorithms for selecting populations and identifying events of interest In Big Data analysis, with over 30 years of experience in biometry and mastery of analytical tools that will optimize the use of secondary data (propensity score, modelling, clustering) |
||